The medication is commonly used in adults for managing symptoms related to physical discomfort and acute episodes. The medication is applied across domains where additional symptomatic support is needed. The medication is used within therapeutic areas involving heightened responses and helps address symptoms related to inflammatory or irritative states.

Dexketoprofeno Teva is relevant when supportive symptom management is appropriate during various acute episodes. This medication helps manage symptoms associated with physical discomfort following dental procedures, acute musculoskeletal issues like sprains and strains, and the discomfort of dysmenorrhea (menstrual pain). This support contributes to easing the overall symptom load.

“The medication may assist with managing symptoms that create noticeable physiological strain during acute episodes, providing supportive relief when symptoms interfere with routine activities.”

Support for Acute Symptoms and Discomfort

This medication generally helps address symptom clusters that may become intense or disruptive, such as pain, localized swelling, and fever. It is relevant for easing symptoms related to heightened physiological activity, especially in clinical settings that involve acute or unstable symptom patterns.

Quick Fact: Relief for Pain and Inflammation
Commonly used for: Relevant in conditions involving inflammatory or irritative processes, particularly during acute episodes.
Primary benefit: Contributes to maintaining functional stability when symptoms interfere with routine activities.
Target symptom severity: Applied when symptoms associated with physical discomfort escalate temporarily.

Dexketoprofeno Teva, a non-steroidal anti-inflammatory drug (NSAID), is generally intended for adults for the short-term relief of mild to moderate pain. Its use is determined by a patient's medical history and current health status.

---

Who CAN Use Dexketoprofeno Teva?

Patient Group	Indication
Adults	Short-term relief of various pain types (e.g., musculoskeletal, dental, menstrual).

---

Who CANNOT Use Dexketoprofeno Teva?

This medication is contraindicated in individuals with a number of specific conditions, as the risks often outweigh the benefits. Do not use Dexketoprofeno Teva if you fall into any of the categories listed below:

• Children and adolescents (under 18 years of age).
• Late pregnancy (third trimester) and breastfeeding.
• Individuals with a history of asthma, bronchospasm, acute rhinitis, or hives following use of NSAIDs or aspirin.
• Active or history of gastrointestinal bleeding, peptic ulcer, or chronic dyspepsia.
• Severe heart failure, kidney impairment, or liver impairment.
• Active bleeding disorders or taking anticoagulants.

Dexketoprofeno Teva is a Non-Steroidal Anti-Inflammatory Drug (NSAID) and may interact with other medicines. Always inform your doctor or pharmacist of all medications you are taking, including over-the-counter and herbal remedies, to prevent potentially serious interactions.

Medications with Increased Risks

Concomitant use of Dexketoprofeno Teva with the following medicines is generally not recommended or requires close medical supervision, as it can increase the risk of bleeding, ulceration, or toxicity:

• Other NSAIDs (including aspirin or other non-selective NSAIDs and COX-2 inhibitors): This combination significantly raises the risk of gastrointestinal ulcers and bleeding.
• Anticoagulants (e.g., warfarin, heparin): Dexketoprofen can enhance the effects of blood thinners, increasing the risk of serious hemorrhage.
• Corticosteroids (e.g., prednisone): Increased risk of gastrointestinal ulceration or bleeding.
• Lithium: NSAIDs can elevate lithium plasma levels, potentially leading to toxicity.
• Methotrexate (when used at high doses geq 15 mg/week): Increased blood levels of methotrexate, leading to greater toxicity.
• Selective Serotonin Reuptake Inhibitors (SSRIs) (e.g., sertraline): Increased risk of gastrointestinal bleeding.
• Diuretics (e.g., furosemide) and ACE Inhibitors (e.g., lisinopril) or Angiotensin II Receptor Blockers (ARBs): Combining these with Dexketoprofeno Teva can impair kidney function, particularly in dehydrated or elderly patients.

Other Important Interactions

Dexketoprofeno Teva may also interact with medicines used for diabetes (sulfonylureas) or ciclosporin and tacrolimus, increasing the risk of kidney problems. Alcohol consumption should be avoided as it raises the risk of stomach bleeding.

️ Core Mechanism: Inhibition of Prostaglandin Synthesis

Dexketoprofen, specifically the active (S)-enantiomer, operates by competitively inhibiting the activity of Cyclooxygenase ( COX) enzymes ( COX-1 and COX-2). This molecular inhibition prevents the conversion of arachidonic acid into key Prostaglandins ( PGE2, PGF2alpha) and related lipid mediators. This initial suppression of eicosanoid production modifies an early step in the signaling cascade, which results in the modulation of vascular and inflammatory pathway signaling.

Dampening Peripheral Nociceptive Signal Transduction

The mechanism affects systems where Prostaglandins function as sensitizers of sensory nerve endings. By reducing the local presence of these mediators in the tissues, the drug directly dampens the excitability of peripheral nociceptors, affecting the transmission intensity of nociceptive impulses. This suppression further limits the influence of pro-inflammatory mediators on local blood vessels, altering tissue-level responses associated with inflammation.

️ Central Modulation of Thermoregulatory Signals

The mechanism also engages the central pathways that influence body temperature. By preventing PGE2 formation within the hypothalamus, the drug facilitates the modulation of an elevated thermal set point. This central action on the thermal control center resets the elevated set point, leading to peripheral heat-dissipating adjustments, which influences the core body temperature.

How to Use Dexketoprofeno Teva: Official Administration Guidelines

Dexketoprofeno Teva is officially used through both oral and parenteral routes, providing flexibility based on the clinical situation. Oral administration involves film-coated tablets or granules for oral solution, typically containing 25 mg of the active substance. The injectable solution is 50 mg/2 ml and is designated for intramuscular (IM) or intravenous (IV) use when oral intake is inappropriate, such as for severe acute pain.

---

Dosing and Administration Patterns

The standard oral dose is generally 25 mg every 8 hours, or 12.5 mg every 4–6 hours, with a total daily dose limit of 75 mg. For acute pain, the oral form is officially recommended to be taken 15 to 30 minutes before meals to enhance the speed of absorption. The parenteral dose is 50 mg every 8–12 hours, limited to a maximum daily total of 150 mg.

Administration of the parenteral solution is highly procedural: an IV bolus must be administered over no less than 15 seconds, while an IV infusion should last 10 to 30 minutes.

---

Duration and Population Adjustments

Use of the injectable formulation is strictly limited to the acute symptomatic period, requiring a mandatory switch to the oral form after no more than two consecutive days of treatment. The oral form is also intended for short-term use, limited to the symptomatic period.

Special dosing rules apply to specific populations. The initial total daily dose is reduced to 50 mg for older adults and for patients with mild hepatic or mild renal impairment. The product is not recommended for use in the pediatric population, as its safety and efficacy have not been established in this group.

Evidence for Pain Following Dental Procedures

The research base consists primarily of short-term, randomized controlled trials (RCTs) and systematic reviews applied to adult patients with moderate to severe pain after dental procedures. Researchers examined objective measures like pain intensity (VAS/NRS), total pain change measured over a defined period, and the need for rescue medication. Findings describe patterns observed in these short-term pain intensity measurements and changes recorded in the initial hours after administration. What remains uncertain is the duration of follow-up. Since studies focused on the immediate aftermath, evidence provides limited insight into long-term outcomes or sustained pain management over weeks.

---

Evidence for Acute Musculoskeletal Pain

This medicine was studied for acute musculoskeletal pain, such as sprains and strains, in RCTs and comparator trials involving adults with acute episodes. Studies explored outcomes related to physical discomfort, monitoring changes in pain intensity scores, and outcomes reflecting daily functioning or activity level. Findings describe patterns observed in relation to these functional and pain outcomes. A key limitation is that follow-up durations were limited, typically lasting only a couple of weeks. This means data for long-term outcomes concerning pain recurrence or outcomes reflecting daily functioning are not fully established.

---

Evidence for Dysmenorrhea (Menstrual Pain)

The evidence for primary dysmenorrhea was evaluated in RCTs and systematic reviews on adult female patients experiencing episodic pain. Study outcomes examined patient-reported outcomes describing perceived discomfort and pain intensity changes during the acute menstrual phase. Findings describe patterns observed over defined time intervals. What remains uncertain is that fewer dedicated, large-scale studies have been conducted, and research explored only short-term symptom changes. There is limited information for long-term outcomes across multiple menstrual cycles.

---

Long-Term Research and Evidence Gaps

The majority of clinical research focuses on short-term changes related to physical discomfort, with follow-up measured in hours or a few days. Therefore, long-term effects are not fully established, and evidence for sustained use is limited. The evidence quality varies across studies, and subgroup findings remain uncertain for patients such as older adults or those with pre-existing conditions not typically included in the original trials. Research is ongoing to explore these gaps and contribute to the broader evidence landscape.

Common questions about Dexketoprofeno Teva (FAQ)

Q: Is Dexketoprofeno Teva a type of aspirin or ibuprofen?

A: Official product information states that this medicine is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This is the same drug class of medicines as ibuprofen and aspirin. It is a derivative of propionic acid, which acts by reducing the body's production of substances that cause inflammation and pain.

Q: What is the main difference between Dexketoprofeno and regular Ketoprofen?

A: The medicine contains dexketoprofen, which is the active S-(+)-enantiomer (active component) of the NSAID ketoprofen. It is formulated in this way to concentrate the therapeutic effect on the active component. This formulation is designed to focus the therapeutic effect on the active component.

Q: How quickly should I expect Dexketoprofeno Teva to start working?

A: Studies on the medicine's effectiveness show that the onset of analgesic activity has been demonstrated in some people within 30 minutes after taking the tablet. This is due to its fast absorption when administered orally.

Q: How long does the pain relief from one dose of Dexketoprofeno Teva usually last?

A: According to the official product information, the pain-relieving effect from a single dose typically lasts for 4 to 6 hours.

Q: Can Dexketoprofeno Teva affect my sleep or make me drowsy?

A: Yes, sleepiness or somnolence is listed as a common side effect of the medicine. Disturbed sleep (insomnia) is also listed as an uncommon side effect in regulatory documents. Regulatory warnings indicate that due to possible dizziness or drowsiness, care should be exercised when driving or operating machinery.

Q: Does Dexketoprofeno Teva cause changes in blood pressure for some people?

A: Yes, high blood pressure (hypertension) is listed as an uncommon side effect of this medicine. Official documents also advise caution for patients who have pre-existing, uncontrolled high blood pressure.

Q: What are the chances of getting a skin rash while using this medicine?

A: A skin rash is listed as an uncommon undesirable effect in the regulatory documents. This means it may affect up to 1 in 100 people who use the medicine.

Q: Are there any common foods or drinks that should be avoided when taking Dexketoprofeno Teva?

A: Regulatory documents state that alcohol consumption increases the risk of serious gastrointestinal bleeding and is therefore generally not recommended with this medicine. For the fastest effect, the tablets are intended to be taken at least 30 minutes before meals.

Q: Can people with liver issues use Dexketoprofeno Teva?

A: The medicine is contraindicated (must not be used) in patients with severe liver impairment. For patients with mild to moderate liver impairment, official documents indicate that a reduced initial total daily dose is used, and close monitoring is required.

Q: Can older adults (70+) take Dexketoprofeno Teva safely?

A: Regulatory information recommends starting therapy for older adults with a reduced initial total daily dose. This lower dose is used because older individuals may be more likely to suffer from side effects. The dosage may be increased only after tolerance has been confirmed, according to official guidelines.

Q: Why are people with kidney problems usually advised against taking this kind of drug?

A: As with other NSAIDs, this medicine works by inhibiting prostaglandin synthesis, which is a process that can negatively affect the renal system. Official warnings indicate that this effect can lead to deterioration of kidney function, fluid retention, and oedema (swelling).

Q: Is there a risk of becoming dependent on Dexketoprofeno Teva if I take it for a long time?

A: According to the official patient information, there have been no habit-forming tendencies (drug dependency) reported for this medicine.

Q: Is Dexketoprofeno Teva considered a strong painkiller?

A: The medicine is officially indicated for the symptomatic treatment of pain that is mild to moderate in intensity. It is not intended for the management of severe pain.

Q: Can taking Dexketoprofeno Teva cause heartburn or acid reflux?

A: Yes, common gastrointestinal side effects listed in the product documents include indigestion (dyspepsia) and stomach pain. These symptoms are related to the discomfort often associated with heartburn and acid reflux.

Q: What is the risk of having an allergic reaction to Dexketoprofeno Teva?

A: Milder allergic reactions like a skin rash are uncommon side effects. However, severe acute hypersensitivity reactions (including anaphylactic shock) are rare, but have been observed on very rare occasions.

Q: Why does the packaging say to use the lowest effective dose for the shortest time?

A: This specific advice is given in the official product documents to minimize the risk of undesirable effects. These risks are particularly related to the gastrointestinal (stomach and gut) and cardiovascular (heart and blood vessel) systems.

Q: Is Dexketoprofeno Teva used for inflammatory conditions like arthritis?

A: The medicine does possess anti-inflammatory properties and is used for acute musculoskeletal pain. However, it is explicitly indicated for short-term use only to relieve symptoms, limiting its role in the long-term management of chronic inflammatory conditions like most forms of arthritis.

Q: Is it normal to feel a bit light-headed when starting Dexketoprofeno Teva?

A: Yes, dizziness is listed as a common side effect of this medicine. Regulatory warnings indicate that due to the possibility of dizziness, caution should be exercised when driving or operating machinery.

Q: Is it possible to take Dexketoprofeno Teva with a cold or flu medicine?

A: Caution is advised, as many over-the-counter cold and flu remedies contain other NSAIDs or similar painkillers. Official documentation notes that combining multiple NSAIDs is not advised.

Q: Are there common symptoms that indicate a serious interaction with Dexketoprofeno Teva?

A: Official safety documents list symptoms of serious concern. These include signs of gastrointestinal bleeding, such as passing blood or black, tarry stools and vomiting blood. Difficulty breathing or swelling of the face, hands, or throat also warrant immediate medical attention.

Q: What is the half-life of Dexketoprofeno Teva in the body?

A: The mean elimination half-life of the active substance, dexketoprofen, is approximately 1.65 hours. This value indicates the time it takes for half of the drug to be eliminated from the body.

Q: Does Dexketoprofeno Teva contain gluten, lactose, or other common allergens?

A: The official documentation lists all inactive ingredients (excipients). To determine the presence of substances like lactose, gluten, or other specific allergens, the complete list of excipients for a specific product formulation should be consulted.

Q: Does the official documentation mention any impact on fertility for men or women?

A: Yes, as with other NSAIDs, official documents state that the use of this medicine may impair female fertility. Therefore, it is not recommended for women who are trying to conceive or undergoing fertility investigations.

Q: Why is it advised to drink a full glass of water when taking the tablet?

A: The official administration instructions advise swallowing the tablet with a sufficient amount of fluid, such as a glass of water. This ensures proper and timely transit of the tablet through the digestive system.

How to Store and Dispose of Dexketoprofeno Teva?

Regulatory documentation outlines the mandatory storage and disposal conditions to maintain product stability and safety.

Storage Condition	Official Requirement
Temperature	Store below 30°C for PVC-aluminium blisters. Other blister types do not require special temperature conditions.
Light Protection	Must be kept in the outer carton or original package to protect from light.
Child Safety	Keep out of the reach and sight of children.
Stability	Do not use the medicine after the expiry date printed on the carton.
Disposal	Any unused medicinal product or waste material must be disposed of in accordance with local requirements.

These official rules define how the product must be stored, handled, and discarded. The primary constraints involve conditional temperature control and the universal requirement for light protection across all packaging forms. The mandated disposal protocol ensures the correct and safe end-of-life handling of the pharmaceutical product.